These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 2601095
1. [F-18 FDG PET in dementia]. Ichiya Y. Rinsho Hoshasen; 1989 Oct; 34(11):1337-41. PubMed ID: 2601095 [Abstract] [Full Text] [Related]
2. [Cerebral glucose metabolism in dementia (PET-FDG study)]. Hatazawa J, Itoh M, Matsuzawa T. Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096 [Abstract] [Full Text] [Related]
3. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study. Brunetti A, Berg G, Di Chiro G, Cohen RM, Yarchoan R, Pizzo PA, Broder S, Eddy J, Fulham MJ, Finn RD. J Nucl Med; 1989 May; 30(5):581-90. PubMed ID: 2785582 [Abstract] [Full Text] [Related]
4. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY. Arch Neurol; 1983 Nov; 40(12):711-4. PubMed ID: 6605139 [Abstract] [Full Text] [Related]
5. Cerebral glucose metabolism in patients with frontotemporal dementia. Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, Imamura T, Shimomura T, Hirono N, Mori E. J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574 [Abstract] [Full Text] [Related]
6. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease]. Arahata Y, Kato T, Tadokoro M, Sobue G. Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454 [Abstract] [Full Text] [Related]
7. FDG PET imaging in patients with pathologically verified dementia. Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, Coleman RE. J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505 [Abstract] [Full Text] [Related]
8. Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia. Sasaki M, Ichiya Y, Hosokawa S, Otsuka M, Kuwabara Y, Fukumura T, Kato M, Goto I, Masuda K. Ann Nucl Med; 1992 Nov; 6(4):241-6. PubMed ID: 1489634 [Abstract] [Full Text] [Related]
9. [A longitudinal study of CMRGlu in dementia of Alzheimer type]. Kuwabara Y, Ichiya Y, Ichimiya A, Sasaki M, Akashi Y, Yoshida T, Fukumura T, Masuda K. Kaku Igaku; 1994 Oct; 31(10):1255-60. PubMed ID: 7807730 [Abstract] [Full Text] [Related]
10. Characteristics of cerebral glucose utilization in dementia. Matsuzawa T, Matsui H, Meguro K, Ueda M, Yamada K, Yamaguchi T, Itoh M, Hatazawa J, Kinomura S. Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):11-21. PubMed ID: 2103655 [Abstract] [Full Text] [Related]
11. Functional brain imaging in late-life depression and dementia. Kumar A. J Clin Psychiatry; 1993 Nov; 54 Suppl():21-5. PubMed ID: 8270594 [Abstract] [Full Text] [Related]
16. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method. Kuhl DE, Metter EJ, Riege WH, Phelps ME. J Cereb Blood Flow Metab; 1982 Nov; 2(2):163-71. PubMed ID: 6978885 [Abstract] [Full Text] [Related]
18. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH, Derenzo SE. J Comput Assist Tomogr; 1983 Aug; 7(4):590-8. PubMed ID: 6602819 [Abstract] [Full Text] [Related]
19. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S, Riemenschneider M, Förstl H, Schwaiger M, Kurz A. Neurobiol Aging; 2007 Jan; 28(1):42-50. PubMed ID: 16448722 [Abstract] [Full Text] [Related]